NCT07195955

Brief Summary

Heparin is a widely used anticoagulant for thrombosis prevention, and low molecular weight heparin (LMWH) has become the preferred option due to its higher bioavailability, strong antithrombotic effect, and lower risk of complications. However, subcutaneous LMWH injections-commonly administered in the abdomen, arm, or thigh-often cause local side effects such as pain, ecchymosis, and hematoma. The incidence of ecchymosis after injection ranges between 26-89%, and various factors such as injection site, needle size, injection duration, and techniques can influence these outcomes. Cold application is frequently used to reduce injection-related pain and bruising by inducing vasoconstriction, decreasing nerve conduction, and increasing pain tolerance. In orthopedic surgery patients, limited injection sites due to dressings, casts, or splints may increase the risk of repeated bruising and pain. Although cold compresses have been studied in reducing injection-related complications, no research has evaluated the effect of cold spray prior to LMWH administration in this patient group. Therefore, standardized studies are needed to determine whether cold spray is an effective, practical alternative for reducing pain and ecchymosis following LMWH prophylaxis after orthopedic surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2024

Completed
2 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 3, 2024

Completed
12 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

September 19, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 29, 2025

Completed
Last Updated

October 7, 2025

Status Verified

October 1, 2025

Enrollment Period

2 days

First QC Date

September 19, 2025

Last Update Submit

October 2, 2025

Conditions

Keywords

nursing carecold applicationpainecchymosis

Outcome Measures

Primary Outcomes (2)

  • Pain Intensity

    Pain intensity at the injection site will be measured using the Visual Analog Scale (VAS). 10-cm VAS scale (0 = no pain, 10 = worst possible pain).

    Immediately after each LMWH injection.

  • Ecchymosis Area

    The size of ecchymosis at the injection site will be measured using the Opsite-Flexigrid transparent film. Area calculated in cm² by tracing the ecchymosis on the grid.

    48 and 72 hours after injection.

Study Arms (2)

Cold Spray Application

EXPERIMENTAL

In patients who receive standard and routine subcutaneous low molecular weight heparin (LMWH) prophylaxis after orthopedic surgery, cold spray is applied to the injection site before this injection.

Other: Cold Spray Application

Standart (Routine) Care

NO INTERVENTION

This injection is administered without cold application to patients receiving standard and routine subcutaneous low molecular weight heparin (LMWH) prophylaxis after orthopedic surgery.

Interventions

A cold spray is applied to the skin at the planned injection site immediately before LMWH administration to reduce pain and ecchymosis.

Cold Spray Application

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who are:
  • years of age or older
  • Receiving 1 x 0.4 ml anticoagulant therapy
  • Are on the first day of LMWH therapy
  • Have no infection, scar tissue, lipodystrophy, or incision at the injection site
  • Have not received any other parenteral therapy at the injection site
  • Are not allergic to cold or heparin
  • Volunteer to participate in the study

You may not qualify if:

  • Patients were excluded from the study if they were: • Pregnant, • Had any acute or chronic coagulation disorder or hematological disease,
  • Had a subcutaneous injection into the same area 24 hours prior,
  • Wanted to withdraw from the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kocaeli University

Köseköy, Kocaeli, 41100, Turkey (Türkiye)

Location

Related Publications (16)

  • Ekanayake C, Gamage JCPH, Mendis P, Weerasinghe P. Revolution in orthopedic immobilization materials: A comprehensive review. Heliyon. 2023 Feb 16;9(3):e13640. doi: 10.1016/j.heliyon.2023.e13640. eCollection 2023 Mar.

  • Sendir M, Buyukyilmaz F, Celik Z, Taskopru I. Comparison of 3 methods to prevent pain and bruising after subcutaneous heparin administration. Clin Nurse Spec. 2015 May-Jun;29(3):174-80. doi: 10.1097/NUR.0000000000000129.

  • Erek Kazan, E. (2021). Hot and cold applications. In M. Kara Kaşıkçı & E. Akın (Eds.), Fundamentals of nursing: Concepts, principles, practices (1st ed., pp. 492-515). Istanbul Medical Bookstores.

    RESULT
  • Lafcı, D. (2021). Hot and cold applications. In N. Sabuncu, S. Erkal İlhan, & Z. Koç (Eds.), Fundamentals of nursing care: Concepts, principles, practices (pp. 801-823). Alter Publishing.

    RESULT
  • Çalışkan, N. (2021). Hot and cold applications. In T. Atabek Aşti & A. Karadağ (Eds.), Fundamentals of nursing: From knowledge to practice - Concepts, principles, skills (2nd ed., pp. 567-586). Akademi Publishing.

    RESULT
  • Altaie, A. H., AbdulRazzaq, H. A., & Abd Al-hadi, A. (2013). Dose effect and risk factors on the severity of enoxaparin bruising side effect. International Journal of Clinical Pharmacy, 35(5), 950.

    RESULT
  • Palese A, Aidone E, Dante A, Pea F. Occurrence and extent of bruising according to duration of administration of subcutaneous low-molecular-weight heparin: a quasi-experimental case-crossover study. J Cardiovasc Nurs. 2013 Sep-Oct;28(5):473-82. doi: 10.1097/JCN.0b013e3182578b87.

  • Bayram SB, Gulnar E, Caliskan N, Kosucu P, Bektas O, Bayram A, Aksoy F. The Effect of Two Types of Subcutaneous Heparin Injections on Pain, Ecchymosis, Hematoma and Drug Absorption: A Quasi-Experimental Study. J Eval Clin Pract. 2025 Feb;31(1):e14266. doi: 10.1111/jep.14266.

  • Amaniyan S, Varaei S, Vaismoradi M, Haghani H, Sieloff C. Effect of local cold and hot pack on the bruising of enoxaparin sodium injection site: a randomized controlled trial. Contemp Nurse. 2016 Feb;52(1):30-41. doi: 10.1080/10376178.2016.1190289. Epub 2016 Jun 5.

  • Karadag S, Aydinli A, Yilmaz C, Tutar N. Effect of cold application and compression on pain and bruising in subcutaneous heparin injection. J Vasc Nurs. 2023 Mar;41(1):22-26. doi: 10.1016/j.jvn.2023.01.002. Epub 2023 Jan 17.

  • Tosun, H. (2019). Medication management: Oral and local drug administration. In T. Atabek Aşti & A. Karadağ (Eds.), Fundamentals of nursing: From knowledge to practice - Concepts, principles, skills. Akademi Publishing.

    RESULT
  • Taylor, C., Lynn, P., & Bartlett, J. (2018). Fundamentals of nursing: The art and science of person-centered care (pp. 59-380). Wolters Kluwer.

    RESULT
  • Duruk, N. (2023). Nursing functions and roles. In M. Kara Kaşıkçı & E. Akın (Eds.), Fundamentals of nursing: Concepts, principles, practices (pp. 11-17). Istanbul Medical Bookstores.

    RESULT
  • Flevas DA, Megaloikonomos PD, Dimopoulos L, Mitsiokapa E, Koulouvaris P, Mavrogenis AF. Thromboembolism prophylaxis in orthopaedics: an update. EFORT Open Rev. 2018 Apr 27;3(4):136-148. doi: 10.1302/2058-5241.3.170018. eCollection 2018 Apr.

  • Hallan SS, Kaur V, Jain V, Mishra N. Development and characterization of polymer lipid hybrid nanoparticles for oral delivery of LMWH. Artif Cells Nanomed Biotechnol. 2017 Dec;45(8):1631-1639. doi: 10.1080/21691401.2016.1276920. Epub 2017 Jan 10.

  • Wang H, Guan J, Zhang X, Wang X, Ji T, Hou D, Wang G, Sun J. Effect of Cold Application on Pain and Bruising in Patients With Subcutaneous Injection of Low-Molecular-Weight Heparin: A Meta-Analysis. Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620905349. doi: 10.1177/1076029620905349.

MeSH Terms

Conditions

PainEcchymosis

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsBlood Coagulation DisordersHematologic DiseasesHemic and Lymphatic DiseasesHemorrhagePathologic ProcessesSkin Manifestations

Study Officials

  • YASEMİN ÖZHANLI, Assist.Prof

    Kocaeli University

    STUDY DIRECTOR
  • HATİCE MERVE ALPTEKİN, Research Assistant

    Kocaeli University

    STUDY CHAIR
  • ALİ OSMAN ALTUNTAŞ, Student

    Kocaeli University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The study employed a single-blind design. To prevent bias in the analysis of the research data, blinding was also applied to the outcomes assessor and statistician. The care provider and researcher in the study were composed of different individuals. When coding the research data, the study groups were coded as A and B, preventing the statistician from knowing which letter represented which group.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: The study was conducted experimentally with a pre-test and post-test control group.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

September 19, 2025

First Posted

September 29, 2025

Study Start

February 1, 2024

Primary Completion

February 3, 2024

Study Completion

February 1, 2025

Last Updated

October 7, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations